← Leaderboards
Brent A French
University Of Virginia
$10,427,669
Attributed
$14,749,358
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,749,358 · 9
By mechanism
R01$13,446,929 · 8
P01$1,302,429 · 1
Top collaborators
- Irving L Kron5 shared
- Brian H Annex4 shared
- Kimberly A. Kelly4 shared
- Craig D Logsdon4 shared
- Jonathan R Lindner2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Justin S. Hanes$23,093,683
- Richard J Price$15,866,868
- Jonathan R Lindner$23,863,903
- Kimberly A. Kelly$7,276,942
Others in their field
Top investigators on “Tissues”
- David Heimbrook · Leidos Biomedical Research, Inc.$346,311,904
- Lawrence Corey · Fred Hutchinson Cancer Center$230,011,824
- Larry Arthur$159,140,370
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Judith S. Currier · University Of California Los Angeles$138,805,403
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$138,805,403
Research focus
TissuesMyocardial InfarctionHeartGene ExpressionAnimal ModelIn VivoMediatingClinically RelevantInflammationGene TherapyCardiacPathway InteractionsCell TypeMouse ModelMyocardial IschemiaCessation Of LifeGene DeliveryVectorAccountingInsightInterdisciplinary ApproachPlayCellsGenes
Grant awards (36)
Ultrasound Cavitation for Facilitated Cardiac Transduction of AAV$711,332
R01 · FY2025 · HL
Ultrasound Cavitation for Facilitated Cardiac Transduction of AAV$694,385
R01 · FY2024 · HL
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction$403,750
R01 · FY2022 · HL · contact PI
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction$403,750
R01 · FY2021 · HL · contact PI
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction$403,750
R01 · FY2020 · HL · contact PI
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction$403,750
R01 · FY2019 · HL · contact PI
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$691,315
R01 · FY2017 · HL
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$489,556
R01 · FY2017 · CA
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$681,405
R01 · FY2016 · HL
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$489,556
R01 · FY2016 · CA
Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice$384,096
R01 · FY2016 · HL · contact PI
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$675,558
R01 · FY2015 · HL
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$489,556
R01 · FY2015 · CA
Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice$378,334
R01 · FY2015 · HL · contact PI
A Bioengineering Approach to Gene Therapy for Peripheral Arterial Disease$691,170
R01 · FY2014 · HL
Highly Specific and Efficient Vectors for Targeting Pancreatic Cancer$504,056
R01 · FY2014 · CA
Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice$376,414
R01 · FY2014 · HL · contact PI
Multi-parameter CMR of post-MI Left Ventricular Remodeling in Gene Modified Mice$365,659
R01 · FY2013 · HL · contact PI
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size$356,914
R01 · FY2013 · HL · contact PI
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size$374,910
R01 · FY2012 · HL · contact PI
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size$378,697
R01 · FY2011 · HL · contact PI
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size$378,697
R01 · FY2010 · HL · contact PI
Inflammation and Oxidative Stress in Hyperglycemic Exacerbation of Infarct Size$378,697
R01 · FY2009 · HL · contact PI
Cardiopulmonary Response to Lung Injury$334,750
P01 · FY2008 · HL · contact PI
Cardiopulmonary Response to Lung Injury$331,633
P01 · FY2007 · HL · contact PI
Cardiopulmonary Response to Lung Injury$218,311
P01 · FY2006 · HL · contact PI
GENE THERAPY FOR MYOCARDIAL STUNNING AND INFARCTION$214,076
R01 · FY2006 · HL · contact PI
GENE THERAPY FOR MYOCARDIAL STUNNING AND INFARCTION$219,309
R01 · FY2005 · HL
Cardiopulmonary Response to Lung Injury$211,954
P01 · FY2005 · HL
A2a ADENOSINE RECEPTOR IN REMOTE LV DYSFUNCTION POST-MI$367,228
R01 · FY2004 · HL
GENE THERAPY FOR MYOCARDIAL STUNNING AND INFARCTION$219,387
R01 · FY2004 · HL
Cardiopulmonary Response to Lung Injury$205,781
P01 · FY2004 · HL
A2a ADENOSINE RECEPTOR IN REMOTE LV DYSFUNCTION POST-MI$367,309
R01 · FY2003 · HL
GENE THERAPY FOR MYOCARDIAL STUNNING AND INFARCTION$219,463
R01 · FY2003 · HL
A2a ADENOSINE RECEPTOR IN REMOTE LV DYSFUNCTION POST-MI$367,387
R01 · FY2002 · HL
A2a ADENOSINE RECEPTOR IN REMOTE LV DYSFUNCTION POST-MI$367,463
R01 · FY2001 · HL